Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GDF11 ELISA Kit (AC3535)
Cat.#: ASET-2124
Specifications
Description Human GDF11 ELISA Kit allows for the in vitro quantitative determination of human GDF11 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1850 Human Oxytocin-neurophysin 1 ELISA Kit (AC3261) Quantitative inquiry ASET-2482 Mouse ApoER2 ELISA Kit (AC3893) Quantitative inquiry ASET-1037 Mouse GBA ELISA Kit (AC2448) Quantitative inquiry ASET-1465 Human Meteorin ELISA Kit (AC2876) Quantitative inquiry ASET-1475 Human GABARAP ELISA Kit (AC2886) Quantitative inquiry ASET-2244 Human Big Dynorphin ELISA Kit (AC3655) Quantitative inquiry ASET-1397 Human beta III Tubulin ELISA Kit (AC2808) Quantitative inquiry ASET-2186 Human Calretinin ELISA Kit (AC3597) Quantitative inquiry ASET-1749 Human Glutathione Synthetase ELISA Kit (AC3160) Quantitative inquiry ASET-1895 Human TrkB ELISA Kit (AC3306) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket